Resources & Reports

Today the Center for Connected Health Policy (CCHP)is releasing its Summary of state telehealth policy changes for 2024.  Additionally, we are also making available a state summary chart showing where states stand on many key telehealth policies, as well as an infographic highlighting our key findings.  As always, the most current information in CCHP’s online policy finder tool may be exported for each state into a PDF document. Note that the last review period for this report was late May through early September 2024. It is possible that in some cases, after a state was reviewed by CCHP, the state may have passed a significant piece of legislation or implemented an administrative policy change that CCHP may not have captured in this update of the report. Those types of changes will be incorporated into future updates of our online policy finder.

CCHP’s November newsletter is here! This month’s topics include – CMS Releases CY 2025 Physician Fee Schedule with Telehealth Policy Updates and Key Modifications; Expanded Flexibility for Home Health Telehealth Reporting During Inpatient Stays; Key Insights from New IMLCC Reports on Licensing, Physician Impact, and Service Expansion; Another Extension on DEA Telehealth Prescribing Rules for Controlled Substances in White House Review; CMS Clarifies Billing Requirements for Telehealth Medicare Diabetes Self-Management Training (DSMT); Telehealth Proves as Effective as In-Person Care for Early Palliative Treatment in Advanced Lung Cancer.

In October, four US Senators sent requests for more information to two of the largest pharmaceutical companies operating in the United States, Eli Lilly and Pfizer.  The letters concerned both companies’ recent actions in establishing telehealth direct-to-consumer (DTC) platforms. As noted in a press release by Senator Dick Durbin (D-IL), these platforms operate by providing an opportunity for consumers to “talk to a doctor now” after they have read about the company’s medications and the potential benefits.